MLT Research Ltd. se stala dalším členem EDMA

EDMA, the European Diagnostic Manufacturers Association welcomes MLT Research Ltd. as new corporate affiliate, bringing its overall membership up to 27 major IVD companies and 20 National Associations. MLT is a pioneer in the development of highly sensitive diagnostic tests employing molecular technologies including chemiluminescence.

The Molecular Light Technology group or MLT Research Ltd. was set up in 1989 to exploit the methods developed by the University of Wales College of Medicine (UWCM) of using light-emitting (chemiluminescent) molecules as alternatives to radioactive isotopes in diagnostic laboratory tests.

The chemiluminescence technology has had an enormous impact on clinical diagnostic test methods. It forms the basis of a wide range of analytical test products which are used in a diverse range of applications from the measurement of hormones to the detection of micro-organisms. MLT has continued to further develop the use of chemiluminescence technology in research, pharmaceutical and environmental testing applications, and is planning its expansion into the industrial testing sector.

EDMA is looking forward to a fruitful cooperation with MLT to promote In Vitro testing, prevention, early diagnosis and monitoring of treatments, access to innovation, and high quality healthcare.

Background:
EDMA, the European Diagnostic Manufacturers Association represents National Associations and major companies engaged in the research, development, manufacture or distribution of In Vitro Diagnostic (IVD) medical devices in Europe. Through its affiliated National Associations, EDMA represents in total more than 550 companies (or over 1000 legal entities) across Europe. The mission of EDMA is to raise awareness of the importance, usefulness and added-value that diagnostic information can provide to healthcare. For this purpose, EDMA cooperates with European institutions, patients groups, trade associations, health professionals and academia to support an appropriate regulatory system, to work towards a realistic economic environment for healthcare in Europe and to be an effective voice in globalisation.

For more information, please visit EDMA website or contact:
Gloria Galán, EDMA Communications & Public Affairs Manager (Tel. +32 2 777 02 77)